120 related articles for article (PubMed ID: 3124290)
1. The extrinsic fibrinolytic system in survivors of myocardial infarction.
Nilsson TK; Johnson O
Thromb Res; 1987 Dec; 48(6):621-30. PubMed ID: 3124290
[TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
4. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic control, smoking habits and diabetes duration affect the extrinsic fibrinolytic system in type I diabetic patients but microangiopathy does not.
Nilsson TK; Lithner F
Acta Med Scand; 1988; 224(2):123-9. PubMed ID: 3138900
[TBL] [Abstract][Full Text] [Related]
6. The role of the fibrinolytic system in thrombotic disease.
Wiman B
Acta Med Scand Suppl; 1987; 715():169-71. PubMed ID: 3109214
[No Abstract] [Full Text] [Related]
7. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
[TBL] [Abstract][Full Text] [Related]
8. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N
Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
[TBL] [Abstract][Full Text] [Related]
10. Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemia.
Grzywacz A; Elikowski W; Psuja P; Zozulińska M; Zawilska K
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):245-9. PubMed ID: 9663707
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.
Jansson JH; Nilsson TK; Johnson O
Heart; 1998 Oct; 80(4):334-7. PubMed ID: 9875107
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
13. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
15. Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program.
Speiser W; Langer W; Pschaick A; Selmayr E; Ibe B; Nowacki PE; Müller-Berghaus G
Thromb Res; 1988 Sep; 51(5):543-55. PubMed ID: 3140411
[TBL] [Abstract][Full Text] [Related]
16. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients.
Chen HZ; Jia HY; Song HY; Wang JY
Chin Med J (Engl); 1990 Jul; 103(7):541-5. PubMed ID: 2119970
[TBL] [Abstract][Full Text] [Related]
17. Altered fibrinolysis in DVT: influence of site of sampling.
Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
[TBL] [Abstract][Full Text] [Related]
18. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
Barbash GI; Hod H; Roth A; Miller HI; Rath S; Zahav YH; Modan M; Zivelin A; Laniado S; Seligsohn U
Am J Cardiol; 1989 Dec; 64(19):1231-5. PubMed ID: 2511742
[TBL] [Abstract][Full Text] [Related]
19. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase].
Bai XJ; Chen CX; He YL
Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371
[TBL] [Abstract][Full Text] [Related]
20. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors.
Haire WD; Goldsmith JC; Rasmussen J
Am J Hematol; 1989 May; 31(1):36-40. PubMed ID: 2495714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
